Novel Pyrrole Carboxamide Inhibitors of Jak2 as Potential Treatment of Myeloproliferative Disorders.
Brasca, M.G., Gnocchi, P., Nesi, M., Amboldi, N., Avanzi, N., Bertrand, J., Bindi, S., Canevari, G., Casero, D., Ciomei, M., Colombo, N., Cribioli, S., Fachin, G., Felder, E.R., Galvani, A., Isacchi, A., Motto, I., Panzeri, A., Donati, D.(2015) Bioorg Med Chem 23: 2387
- PubMed: 25882525 
- DOI: https://doi.org/10.1016/j.bmc.2015.03.059
- Primary Citation of Related Structures:  
5AEP - PubMed Abstract: 
Compound 1, a hit from the screening of our chemical collection displaying activity against JAK2, was deconstructed for SAR analysis into three regions, which were explored. A series of compounds was synthesized leading to the identification of the potent and orally bioavailable JAK2 inhibitor 16 (NMS-P830), which showed an encouraging tumour growth inhibition in SET-2 xenograft tumour model, with evidence for JAK2 pathway suppression demonstrated by in vivo pharmacodynamic effects ...